chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Thrombosis
Clinical narrative: Patient presented to local hospital on 3/21/21 after feeling unwell, vomiting, and having garbled speech as per her son. She was noted to have left hemiparesis. Her airway was obstructed with emesis and she was emergently  intubated. CT head did not show intracranial hemorrhage or acute mass effect. However, CT angiogram of the head and neck reported : "1. There is fresh-appearing thrombus within the cervical segment of the RIGHT internal carotid artery. The origin of the cervical segment of the right internal carotid artery opacifies normally. It is subsequently narrowed by thrombus, and becomes completely occluded by thrombus approximately 1.5 cm distal to the bifurcation. There is no reconstitution within the neck.   2. The petrous, precavernous, cavernous, and proximal supraclinoid segments of the RIGHT internal carotid artery are occluded. There is reconstitution within the supraclinoid segment of the right internal carotid artery just proximal to the carotid terminus at the level of the origin of the hypoplastic right posterior communicating artery.    3. The proximal intraorbital portion of the RIGHT ophthalmic artery opacifies, however the origin and portion within the optic canal are not visualized.    4. There is diminished opacification and caliber of the RIGHT internal cerebral vein compared to the left side, possibly secondary to ipsilateral cerebral oligemia."  She also was noted to have a first cardiac troponin of 1.5, and EKG reported an anteroseptal infarct, "possibly acute."  She was flown by helicopter Hospital the same night. Platelets count on admission to hospital was 19 and rechecked at hospital at 25. She was given one unit of platelets, and then she was sent to the cardiac cath lab where there was an ostial occlusion of the LAD with thrombus. The cath lab team was unable to aspirate the thrombus due to its size. They placed an LAD stent as well as an intra-aortic balloon pump and sent her back to the ICU. Repeat CBC post-cash lab showed platelet increase to 43, but by the next morning (3/22) platelets went down to 23. On 3/22, she remained hypotensive requiring pressors, developed acute kidney injury, COVID PCR was negative, neuro exam still showed left hemiparesis, and no response to tactile stimuli. Later in the evening, she was noted to have a fixed and dilated R pupil. Patient had another CT head done (non contrast) that reported a large acute infarct in the right ACA territory, with associated swelling and compression of the right lateral ventricle, as well as midline shift to the left of approximately 10 mm.  Patient's husband declined heroic neurosurgical intervention, and she was pronounced dead on 3/23/21 at 0028.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Angiogram cerebral abnormal, Arteriogram carotid abnormal, Brain compression, Brain oedema
Clinical narrative: Patient presented to local hospital on 3/21/21 after feeling unwell, vomiting, and having garbled speech as per her son. She was noted to have left hemiparesis. Her airway was obstructed with emesis and she was emergently  intubated. CT head did not show intracranial hemorrhage or acute mass effect. However, CT angiogram of the head and neck reported : "1. There is fresh-appearing thrombus within the cervical segment of the RIGHT internal carotid artery. The origin of the cervical segment of the right internal carotid artery opacifies normally. It is subsequently narrowed by thrombus, and becomes completely occluded by thrombus approximately 1.5 cm distal to the bifurcation. There is no reconstitution within the neck.   2. The petrous, precavernous, cavernous, and proximal supraclinoid segments of the RIGHT internal carotid artery are occluded. There is reconstitution within the supraclinoid segment of the right internal carotid artery just proximal to the carotid terminus at the level of the origin of the hypoplastic right posterior communicating artery.    3. The proximal intraorbital portion of the RIGHT ophthalmic artery opacifies, however the origin and portion within the optic canal are not visualized.    4. There is diminished opacification and caliber of the RIGHT internal cerebral vein compared to the left side, possibly secondary to ipsilateral cerebral oligemia."  She also was noted to have a first cardiac troponin of 1.5, and EKG reported an anteroseptal infarct, "possibly acute."  She was flown by helicopter Hospital the same night. Platelets count on admission to hospital was 19 and rechecked at hospital at 25. She was given one unit of platelets, and then she was sent to the cardiac cath lab where there was an ostial occlusion of the LAD with thrombus. The cath lab team was unable to aspirate the thrombus due to its size. They placed an LAD stent as well as an intra-aortic balloon pump and sent her back to the ICU. Repeat CBC post-cash lab showed platelet increase to 43, but by the next morning (3/22) platelets went down to 23. On 3/22, she remained hypotensive requiring pressors, developed acute kidney injury, COVID PCR was negative, neuro exam still showed left hemiparesis, and no response to tactile stimuli. Later in the evening, she was noted to have a fixed and dilated R pupil. Patient had another CT head done (non contrast) that reported a large acute infarct in the right ACA territory, with associated swelling and compression of the right lateral ventricle, as well as midline shift to the left of approximately 10 mm.  Patient's husband declined heroic neurosurgical intervention, and she was pronounced dead on 3/23/21 at 0028.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebral infarction, Cerebral mass effect, Computerised tomogram head normal, Coronary artery occlusion, Coronary artery thrombosis
Clinical narrative: Patient presented to local hospital on 3/21/21 after feeling unwell, vomiting, and having garbled speech as per her son. She was noted to have left hemiparesis. Her airway was obstructed with emesis and she was emergently  intubated. CT head did not show intracranial hemorrhage or acute mass effect. However, CT angiogram of the head and neck reported : "1. There is fresh-appearing thrombus within the cervical segment of the RIGHT internal carotid artery. The origin of the cervical segment of the right internal carotid artery opacifies normally. It is subsequently narrowed by thrombus, and becomes completely occluded by thrombus approximately 1.5 cm distal to the bifurcation. There is no reconstitution within the neck.   2. The petrous, precavernous, cavernous, and proximal supraclinoid segments of the RIGHT internal carotid artery are occluded. There is reconstitution within the supraclinoid segment of the right internal carotid artery just proximal to the carotid terminus at the level of the origin of the hypoplastic right posterior communicating artery.    3. The proximal intraorbital portion of the RIGHT ophthalmic artery opacifies, however the origin and portion within the optic canal are not visualized.    4. There is diminished opacification and caliber of the RIGHT internal cerebral vein compared to the left side, possibly secondary to ipsilateral cerebral oligemia."  She also was noted to have a first cardiac troponin of 1.5, and EKG reported an anteroseptal infarct, "possibly acute."  She was flown by helicopter Hospital the same night. Platelets count on admission to hospital was 19 and rechecked at hospital at 25. She was given one unit of platelets, and then she was sent to the cardiac cath lab where there was an ostial occlusion of the LAD with thrombus. The cath lab team was unable to aspirate the thrombus due to its size. They placed an LAD stent as well as an intra-aortic balloon pump and sent her back to the ICU. Repeat CBC post-cash lab showed platelet increase to 43, but by the next morning (3/22) platelets went down to 23. On 3/22, she remained hypotensive requiring pressors, developed acute kidney injury, COVID PCR was negative, neuro exam still showed left hemiparesis, and no response to tactile stimuli. Later in the evening, she was noted to have a fixed and dilated R pupil. Patient had another CT head done (non contrast) that reported a large acute infarct in the right ACA territory, with associated swelling and compression of the right lateral ventricle, as well as midline shift to the left of approximately 10 mm.  Patient's husband declined heroic neurosurgical intervention, and she was pronounced dead on 3/23/21 at 0028.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death, Dysarthria, Electrocardiogram abnormal, Endotracheal intubation, Full blood count abnormal
Clinical narrative: Patient presented to local hospital on 3/21/21 after feeling unwell, vomiting, and having garbled speech as per her son. She was noted to have left hemiparesis. Her airway was obstructed with emesis and she was emergently  intubated. CT head did not show intracranial hemorrhage or acute mass effect. However, CT angiogram of the head and neck reported : "1. There is fresh-appearing thrombus within the cervical segment of the RIGHT internal carotid artery. The origin of the cervical segment of the right internal carotid artery opacifies normally. It is subsequently narrowed by thrombus, and becomes completely occluded by thrombus approximately 1.5 cm distal to the bifurcation. There is no reconstitution within the neck.   2. The petrous, precavernous, cavernous, and proximal supraclinoid segments of the RIGHT internal carotid artery are occluded. There is reconstitution within the supraclinoid segment of the right internal carotid artery just proximal to the carotid terminus at the level of the origin of the hypoplastic right posterior communicating artery.    3. The proximal intraorbital portion of the RIGHT ophthalmic artery opacifies, however the origin and portion within the optic canal are not visualized.    4. There is diminished opacification and caliber of the RIGHT internal cerebral vein compared to the left side, possibly secondary to ipsilateral cerebral oligemia."  She also was noted to have a first cardiac troponin of 1.5, and EKG reported an anteroseptal infarct, "possibly acute."  She was flown by helicopter Hospital the same night. Platelets count on admission to hospital was 19 and rechecked at hospital at 25. She was given one unit of platelets, and then she was sent to the cardiac cath lab where there was an ostial occlusion of the LAD with thrombus. The cath lab team was unable to aspirate the thrombus due to its size. They placed an LAD stent as well as an intra-aortic balloon pump and sent her back to the ICU. Repeat CBC post-cash lab showed platelet increase to 43, but by the next morning (3/22) platelets went down to 23. On 3/22, she remained hypotensive requiring pressors, developed acute kidney injury, COVID PCR was negative, neuro exam still showed left hemiparesis, and no response to tactile stimuli. Later in the evening, she was noted to have a fixed and dilated R pupil. Patient had another CT head done (non contrast) that reported a large acute infarct in the right ACA territory, with associated swelling and compression of the right lateral ventricle, as well as midline shift to the left of approximately 10 mm.  Patient's husband declined heroic neurosurgical intervention, and she was pronounced dead on 3/23/21 at 0028.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hemiparesis, Hypotension, Intra-aortic balloon placement, Malaise, Myocardial infarction
Clinical narrative: Patient presented to local hospital on 3/21/21 after feeling unwell, vomiting, and having garbled speech as per her son. She was noted to have left hemiparesis. Her airway was obstructed with emesis and she was emergently  intubated. CT head did not show intracranial hemorrhage or acute mass effect. However, CT angiogram of the head and neck reported : "1. There is fresh-appearing thrombus within the cervical segment of the RIGHT internal carotid artery. The origin of the cervical segment of the right internal carotid artery opacifies normally. It is subsequently narrowed by thrombus, and becomes completely occluded by thrombus approximately 1.5 cm distal to the bifurcation. There is no reconstitution within the neck.   2. The petrous, precavernous, cavernous, and proximal supraclinoid segments of the RIGHT internal carotid artery are occluded. There is reconstitution within the supraclinoid segment of the right internal carotid artery just proximal to the carotid terminus at the level of the origin of the hypoplastic right posterior communicating artery.    3. The proximal intraorbital portion of the RIGHT ophthalmic artery opacifies, however the origin and portion within the optic canal are not visualized.    4. There is diminished opacification and caliber of the RIGHT internal cerebral vein compared to the left side, possibly secondary to ipsilateral cerebral oligemia."  She also was noted to have a first cardiac troponin of 1.5, and EKG reported an anteroseptal infarct, "possibly acute."  She was flown by helicopter Hospital the same night. Platelets count on admission to hospital was 19 and rechecked at hospital at 25. She was given one unit of platelets, and then she was sent to the cardiac cath lab where there was an ostial occlusion of the LAD with thrombus. The cath lab team was unable to aspirate the thrombus due to its size. They placed an LAD stent as well as an intra-aortic balloon pump and sent her back to the ICU. Repeat CBC post-cash lab showed platelet increase to 43, but by the next morning (3/22) platelets went down to 23. On 3/22, she remained hypotensive requiring pressors, developed acute kidney injury, COVID PCR was negative, neuro exam still showed left hemiparesis, and no response to tactile stimuli. Later in the evening, she was noted to have a fixed and dilated R pupil. Patient had another CT head done (non contrast) that reported a large acute infarct in the right ACA territory, with associated swelling and compression of the right lateral ventricle, as well as midline shift to the left of approximately 10 mm.  Patient's husband declined heroic neurosurgical intervention, and she was pronounced dead on 3/23/21 at 0028.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neurological examination abnormal, Platelet count decreased, Platelet count increased, Pupil fixed, SARS-CoV-2 test negative
Clinical narrative: Patient presented to local hospital on 3/21/21 after feeling unwell, vomiting, and having garbled speech as per her son. She was noted to have left hemiparesis. Her airway was obstructed with emesis and she was emergently  intubated. CT head did not show intracranial hemorrhage or acute mass effect. However, CT angiogram of the head and neck reported : "1. There is fresh-appearing thrombus within the cervical segment of the RIGHT internal carotid artery. The origin of the cervical segment of the right internal carotid artery opacifies normally. It is subsequently narrowed by thrombus, and becomes completely occluded by thrombus approximately 1.5 cm distal to the bifurcation. There is no reconstitution within the neck.   2. The petrous, precavernous, cavernous, and proximal supraclinoid segments of the RIGHT internal carotid artery are occluded. There is reconstitution within the supraclinoid segment of the right internal carotid artery just proximal to the carotid terminus at the level of the origin of the hypoplastic right posterior communicating artery.    3. The proximal intraorbital portion of the RIGHT ophthalmic artery opacifies, however the origin and portion within the optic canal are not visualized.    4. There is diminished opacification and caliber of the RIGHT internal cerebral vein compared to the left side, possibly secondary to ipsilateral cerebral oligemia."  She also was noted to have a first cardiac troponin of 1.5, and EKG reported an anteroseptal infarct, "possibly acute."  She was flown by helicopter Hospital the same night. Platelets count on admission to hospital was 19 and rechecked at hospital at 25. She was given one unit of platelets, and then she was sent to the cardiac cath lab where there was an ostial occlusion of the LAD with thrombus. The cath lab team was unable to aspirate the thrombus due to its size. They placed an LAD stent as well as an intra-aortic balloon pump and sent her back to the ICU. Repeat CBC post-cash lab showed platelet increase to 43, but by the next morning (3/22) platelets went down to 23. On 3/22, she remained hypotensive requiring pressors, developed acute kidney injury, COVID PCR was negative, neuro exam still showed left hemiparesis, and no response to tactile stimuli. Later in the evening, she was noted to have a fixed and dilated R pupil. Patient had another CT head done (non contrast) that reported a large acute infarct in the right ACA territory, with associated swelling and compression of the right lateral ventricle, as well as midline shift to the left of approximately 10 mm.  Patient's husband declined heroic neurosurgical intervention, and she was pronounced dead on 3/23/21 at 0028.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Stent placement, Troponin, Unresponsive to stimuli, Vein disorder, Vomiting
Clinical narrative: Patient presented to local hospital on 3/21/21 after feeling unwell, vomiting, and having garbled speech as per her son. She was noted to have left hemiparesis. Her airway was obstructed with emesis and she was emergently  intubated. CT head did not show intracranial hemorrhage or acute mass effect. However, CT angiogram of the head and neck reported : "1. There is fresh-appearing thrombus within the cervical segment of the RIGHT internal carotid artery. The origin of the cervical segment of the right internal carotid artery opacifies normally. It is subsequently narrowed by thrombus, and becomes completely occluded by thrombus approximately 1.5 cm distal to the bifurcation. There is no reconstitution within the neck.   2. The petrous, precavernous, cavernous, and proximal supraclinoid segments of the RIGHT internal carotid artery are occluded. There is reconstitution within the supraclinoid segment of the right internal carotid artery just proximal to the carotid terminus at the level of the origin of the hypoplastic right posterior communicating artery.    3. The proximal intraorbital portion of the RIGHT ophthalmic artery opacifies, however the origin and portion within the optic canal are not visualized.    4. There is diminished opacification and caliber of the RIGHT internal cerebral vein compared to the left side, possibly secondary to ipsilateral cerebral oligemia."  She also was noted to have a first cardiac troponin of 1.5, and EKG reported an anteroseptal infarct, "possibly acute."  She was flown by helicopter Hospital the same night. Platelets count on admission to hospital was 19 and rechecked at hospital at 25. She was given one unit of platelets, and then she was sent to the cardiac cath lab where there was an ostial occlusion of the LAD with thrombus. The cath lab team was unable to aspirate the thrombus due to its size. They placed an LAD stent as well as an intra-aortic balloon pump and sent her back to the ICU. Repeat CBC post-cash lab showed platelet increase to 43, but by the next morning (3/22) platelets went down to 23. On 3/22, she remained hypotensive requiring pressors, developed acute kidney injury, COVID PCR was negative, neuro exam still showed left hemiparesis, and no response to tactile stimuli. Later in the evening, she was noted to have a fixed and dilated R pupil. Patient had another CT head done (non contrast) that reported a large acute infarct in the right ACA territory, with associated swelling and compression of the right lateral ventricle, as well as midline shift to the left of approximately 10 mm.  Patient's husband declined heroic neurosurgical intervention, and she was pronounced dead on 3/23/21 at 0028.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Headache, Pyrexia, Urticaria
Clinical narrative: Injection was extremely painful.  Injection site was itchy and sore for a few days.  Fever of 101 for about 36 hours starting day after injection.  Round, hard lump (chick pea size) developed at injection site a week or so after injection.  Lump faded over 3-4 weeks.  Left a quarter size indentation about 1/4 inch deep.  My primary physician said there is muscle atrophy and the chemicals in the injection likely killed muscle cells.  Left arm is slightly sore.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site induration, Injection site mass, Injection site pain, Injection site pruritus, Muscle atrophy
Clinical narrative: Injection was extremely painful.  Injection site was itchy and sore for a few days.  Fever of 101 for about 36 hours starting day after injection.  Round, hard lump (chick pea size) developed at injection site a week or so after injection.  Lump faded over 3-4 weeks.  Left a quarter size indentation about 1/4 inch deep.  My primary physician said there is muscle atrophy and the chemicals in the injection likely killed muscle cells.  Left arm is slightly sore.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Injection was extremely painful.  Injection site was itchy and sore for a few days.  Fever of 101 for about 36 hours starting day after injection.  Round, hard lump (chick pea size) developed at injection site a week or so after injection.  Lump faded over 3-4 weeks.  Left a quarter size indentation about 1/4 inch deep.  My primary physician said there is muscle atrophy and the chemicals in the injection likely killed muscle cells.  Left arm is slightly sore.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test, Cardiac function test, Chest X-ray, Dizziness, Dyspnoea
Clinical narrative: Identified PE; Pain moved to right chest; Lower Right Backpain; Breathing difficulty; Off Balance; Dizzy; This is a spontaneous report from a contactable consumer (patient). A 38-year-old male patient received the first dose of BNT162B2 (lot number: EW0153), via an unspecified route of administration in arm right on 16Apr2021 12:15 at single dose for COVID-19 immunisation. Medical history was none. Concomitant medications included vitamin b12 nos (VITAMIN B12) and colecalciferol (D3). On 18Apr2021, the patient went urgent care for breathing difficulty; On 19Apr2021, patient went ER for off balance, dizzy, and breathing difficulty and was prescribed with ibuprofin, meclazine and rest for 8 days; On 07May2021, lower right backpain started (not taken 2nd dose scheduled), on 08May2021, pain moved to right chest; On 09May2021, patient went urgent care-identified PE and admitted to hospital; On 11May2021 discharged; Under blood thinner medication (heprion). Adverse events start date of off balance, dizzy, and breathing difficulty was 18Apr2021 04:00. AEs resulted in: Doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, life threatening illness (immediate risk of death from the event). Patient was hospitalized for 3 days. Covid test post vaccination: Nasal Swab on 09May2021: Negative; Nasal Swab on 09May2021: Negative; Nasal Swab on 19Apr2021: Negative. Outcome of the events was resolving.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, Headache, Heart rate increased, Hypertension, Sleep disorder
Clinical narrative: Identified PE; Pain moved to right chest; Lower Right Backpain; Breathing difficulty; Off Balance; Dizzy; This is a spontaneous report from a contactable consumer (patient). A 38-year-old male patient received the first dose of BNT162B2 (lot number: EW0153), via an unspecified route of administration in arm right on 16Apr2021 12:15 at single dose for COVID-19 immunisation. Medical history was none. Concomitant medications included vitamin b12 nos (VITAMIN B12) and colecalciferol (D3). On 18Apr2021, the patient went urgent care for breathing difficulty; On 19Apr2021, patient went ER for off balance, dizzy, and breathing difficulty and was prescribed with ibuprofin, meclazine and rest for 8 days; On 07May2021, lower right backpain started (not taken 2nd dose scheduled), on 08May2021, pain moved to right chest; On 09May2021, patient went urgent care-identified PE and admitted to hospital; On 11May2021 discharged; Under blood thinner medication (heprion). Adverse events start date of off balance, dizzy, and breathing difficulty was 18Apr2021 04:00. AEs resulted in: Doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, life threatening illness (immediate risk of death from the event). Patient was hospitalized for 3 days. Covid test post vaccination: Nasal Swab on 09May2021: Negative; Nasal Swab on 09May2021: Negative; Nasal Swab on 19Apr2021: Negative. Outcome of the events was resolving.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vaccination complication, Vertigo
Clinical narrative: Identified PE; Pain moved to right chest; Lower Right Backpain; Breathing difficulty; Off Balance; Dizzy; This is a spontaneous report from a contactable consumer (patient). A 38-year-old male patient received the first dose of BNT162B2 (lot number: EW0153), via an unspecified route of administration in arm right on 16Apr2021 12:15 at single dose for COVID-19 immunisation. Medical history was none. Concomitant medications included vitamin b12 nos (VITAMIN B12) and colecalciferol (D3). On 18Apr2021, the patient went urgent care for breathing difficulty; On 19Apr2021, patient went ER for off balance, dizzy, and breathing difficulty and was prescribed with ibuprofin, meclazine and rest for 8 days; On 07May2021, lower right backpain started (not taken 2nd dose scheduled), on 08May2021, pain moved to right chest; On 09May2021, patient went urgent care-identified PE and admitted to hospital; On 11May2021 discharged; Under blood thinner medication (heprion). Adverse events start date of off balance, dizzy, and breathing difficulty was 18Apr2021 04:00. AEs resulted in: Doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, life threatening illness (immediate risk of death from the event). Patient was hospitalized for 3 days. Covid test post vaccination: Nasal Swab on 09May2021: Negative; Nasal Swab on 09May2021: Negative; Nasal Swab on 19Apr2021: Negative. Outcome of the events was resolving.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Back pain, Balance disorder, Chest pain, Dizziness, Dyspnoea
Clinical narrative: Identified PE; Pain moved to right chest; Lower Right Backpain; Breathing difficulty; Off Balance; Dizzy; This is a spontaneous report from a contactable consumer (patient). A 38-year-old male patient received the first dose of BNT162B2 (lot number: EW0153), via an unspecified route of administration in arm right on 16Apr2021 12:15 at single dose for COVID-19 immunisation. Medical history was none. Concomitant medications included vitamin b12 nos (VITAMIN B12) and colecalciferol (D3). On 18Apr2021, the patient went urgent care for breathing difficulty; On 19Apr2021, patient went ER for off balance, dizzy, and breathing difficulty and was prescribed with ibuprofin, meclazine and rest for 8 days; On 07May2021, lower right backpain started (not taken 2nd dose scheduled), on 08May2021, pain moved to right chest; On 09May2021, patient went urgent care-identified PE and admitted to hospital; On 11May2021 discharged; Under blood thinner medication (heprion). Adverse events start date of off balance, dizzy, and breathing difficulty was 18Apr2021 04:00. AEs resulted in: Doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, life threatening illness (immediate risk of death from the event). Patient was hospitalized for 3 days. Covid test post vaccination: Nasal Swab on 09May2021: Negative; Nasal Swab on 09May2021: Negative; Nasal Swab on 19Apr2021: Negative. Outcome of the events was resolving.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulmonary embolism, SARS-CoV-2 test negative
Clinical narrative: Identified PE; Pain moved to right chest; Lower Right Backpain; Breathing difficulty; Off Balance; Dizzy; This is a spontaneous report from a contactable consumer (patient). A 38-year-old male patient received the first dose of BNT162B2 (lot number: EW0153), via an unspecified route of administration in arm right on 16Apr2021 12:15 at single dose for COVID-19 immunisation. Medical history was none. Concomitant medications included vitamin b12 nos (VITAMIN B12) and colecalciferol (D3). On 18Apr2021, the patient went urgent care for breathing difficulty; On 19Apr2021, patient went ER for off balance, dizzy, and breathing difficulty and was prescribed with ibuprofin, meclazine and rest for 8 days; On 07May2021, lower right backpain started (not taken 2nd dose scheduled), on 08May2021, pain moved to right chest; On 09May2021, patient went urgent care-identified PE and admitted to hospital; On 11May2021 discharged; Under blood thinner medication (heprion). Adverse events start date of off balance, dizzy, and breathing difficulty was 18Apr2021 04:00. AEs resulted in: Doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, life threatening illness (immediate risk of death from the event). Patient was hospitalized for 3 days. Covid test post vaccination: Nasal Swab on 09May2021: Negative; Nasal Swab on 09May2021: Negative; Nasal Swab on 19Apr2021: Negative. Outcome of the events was resolving.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Brain natriuretic peptide, C-reactive protein increased, Chest X-ray, Computerised tomogram normal
Clinical narrative: 4/14/21 12 hours post shot extreme dyspnea lasting 7 weeks now. Dizzy light headed.Emergency room visit 4/17/21 blood work indicated increase troponin and potential blood clot in lung. Heart attack 4- 27-21. Second ER visit 5/8/21 which showed additional increase in troponin levels. Second heart attack on 5/22/21. Intense back pain between shoulder blades over shoulders and on chest. Additional squeezing in chest and neck pain.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Fibrin D dimer, Full blood count, Troponin
Clinical narrative: 4/14/21 12 hours post shot extreme dyspnea lasting 7 weeks now. Dizzy light headed.Emergency room visit 4/17/21 blood work indicated increase troponin and potential blood clot in lung. Heart attack 4- 27-21. Second ER visit 5/8/21 which showed additional increase in troponin levels. Second heart attack on 5/22/21. Intense back pain between shoulder blades over shoulders and on chest. Additional squeezing in chest and neck pain.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arteriogram, Arthralgia, Back pain, Blood test abnormal, Chest discomfort
Clinical narrative: 4/14/21 12 hours post shot extreme dyspnea lasting 7 weeks now. Dizzy light headed.Emergency room visit 4/17/21 blood work indicated increase troponin and potential blood clot in lung. Heart attack 4- 27-21. Second ER visit 5/8/21 which showed additional increase in troponin levels. Second heart attack on 5/22/21. Intense back pain between shoulder blades over shoulders and on chest. Additional squeezing in chest and neck pain.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Dizziness, Dyspnoea, Echocardiogram, Myocardial infarction
Clinical narrative: 4/14/21 12 hours post shot extreme dyspnea lasting 7 weeks now. Dizzy light headed.Emergency room visit 4/17/21 blood work indicated increase troponin and potential blood clot in lung. Heart attack 4- 27-21. Second ER visit 5/8/21 which showed additional increase in troponin levels. Second heart attack on 5/22/21. Intense back pain between shoulder blades over shoulders and on chest. Additional squeezing in chest and neck pain.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neck pain, Pulmonary function test, Scan with contrast abnormal, Troponin increased
Clinical narrative: 4/14/21 12 hours post shot extreme dyspnea lasting 7 weeks now. Dizzy light headed.Emergency room visit 4/17/21 blood work indicated increase troponin and potential blood clot in lung. Heart attack 4- 27-21. Second ER visit 5/8/21 which showed additional increase in troponin levels. Second heart attack on 5/22/21. Intense back pain between shoulder blades over shoulders and on chest. Additional squeezing in chest and neck pain.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neuropathy peripheral, Pain in extremity, SARS-CoV-2 test, Sensory loss
Clinical narrative: Initially I had pain in my arm at the site of shot. About 2 days after, I had chills and I was tired. About two and a half weeks later, I received light pain in my arm. I took Zorvolex 35mg medication. I woke up with severe pain in my lower arm. Whenever I bend or lean, the pain would intensify. Early in the morning I could barely get ready. I had to do everything with my right arm. I went to Dr that afternoon. I was given Prednisone medication for nerve pain, Tizanidine medication for muscle relaxant. I have been going to different doctors because the pain hasn't gone away and it still hasn't despite multiple medications that I have been on since then. I experienced a sharp pain when the shot was administered. I am limited to what I can do. I have to prevent myself from using my left arm.  Through out the day the pain intensifies. No clear improvements.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Electromyogram abnormal, Fatigue, Injected limb mobility decreased, Injection site pain
Clinical narrative: Initially I had pain in my arm at the site of shot. About 2 days after, I had chills and I was tired. About two and a half weeks later, I received light pain in my arm. I took Zorvolex 35mg medication. I woke up with severe pain in my lower arm. Whenever I bend or lean, the pain would intensify. Early in the morning I could barely get ready. I had to do everything with my right arm. I went to Dr that afternoon. I was given Prednisone medication for nerve pain, Tizanidine medication for muscle relaxant. I have been going to different doctors because the pain hasn't gone away and it still hasn't despite multiple medications that I have been on since then. I experienced a sharp pain when the shot was administered. I am limited to what I can do. I have to prevent myself from using my left arm.  Through out the day the pain intensifies. No clear improvements.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging abnormal, Neuralgia, Neuropathy peripheral, Pain in extremity, Radiculopathy
Clinical narrative: Initially I had pain in my arm at the site of shot. About 2 days after, I had chills and I was tired. About two and a half weeks later, I received light pain in my arm. I took Zorvolex 35mg medication. I woke up with severe pain in my lower arm. Whenever I bend or lean, the pain would intensify. Early in the morning I could barely get ready. I had to do everything with my right arm. I went to Dr that afternoon. I was given Prednisone medication for nerve pain, Tizanidine medication for muscle relaxant. I have been going to different doctors because the pain hasn't gone away and it still hasn't despite multiple medications that I have been on since then. I experienced a sharp pain when the shot was administered. I am limited to what I can do. I have to prevent myself from using my left arm.  Through out the day the pain intensifies. No clear improvements.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, C-reactive protein increased, Chest pain, Cytomegalovirus test negative, Diarrhoea
Clinical narrative: myocarditis ECHO and multiple MRIs done, patient then left before treatment could have been done. Was treated with antibiotics left
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Echocardiogram normal, Electrocardiogram T wave inversion, Epstein-Barr virus antibody positive, HIV test negative
Clinical narrative: myocarditis ECHO and multiple MRIs done, patient then left before treatment could have been done. Was treated with antibiotics left
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: International normalised ratio increased, Mononucleosis heterophile test negative, Nausea, Oropharyngeal pain, Pain
Clinical narrative: myocarditis ECHO and multiple MRIs done, patient then left before treatment could have been done. Was treated with antibiotics left
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Platelet count increased, Pleuritic pain, Procalcitonin increased, Pyrexia, Streptococcus test negative
Clinical narrative: myocarditis ECHO and multiple MRIs done, patient then left before treatment could have been done. Was treated with antibiotics left
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin increased, Vomiting, White blood cell count increased
Clinical narrative: myocarditis ECHO and multiple MRIs done, patient then left before treatment could have been done. Was treated with antibiotics left
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram abnormal, Magnetic resonance imaging, Myocarditis
Clinical narrative: myocarditis ECHO and multiple MRIs done, patient then left before treatment could have been done. Was treated with antibiotics left
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Throat tightness
Clinical narrative: Sensation of throat closing and unable to swallow; slight headache.  Patient is treated with diphenhydramine 50mg orally and prednisone 60mg orally.  Doctor's notes state patient had soft palate edema that started 10-15 minutes after 2nd covid vaccine. Patient is prescribed a short course of steroids to take at home.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac monitoring, Dysphagia, Headache, Oedema mouth, Throat tightness
Clinical narrative: Sensation of throat closing and unable to swallow; slight headache.  Patient is treated with diphenhydramine 50mg orally and prednisone 60mg orally.  Doctor's notes state patient had soft palate edema that started 10-15 minutes after 2nd covid vaccine. Patient is prescribed a short course of steroids to take at home.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Chills, Hepatic pain, Hepatitis
Clinical narrative: Liver pain and inflammation; Liver pain; Stomach Cramps; chills; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot ER8736, second dose) solution for injection intramuscular in the right arm on 28Apr2021 at 15:00 (at the age of 33-years-old) as a single dose for COVID-19 vaccination. There was no medical history. There were no concomitant medications. There was no past drug history. Historical vaccine included BNT162B2 (first dose, lot ER8729) for COVID-19 vaccination on 07Apr2021 with no adverse effect reported. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 28Apr2021 at 18:00, the patient experienced liver pain and inflammation, stomach cramps, chills. There was no treatment for the events. The outcome of the events liver pain and inflammation, stomach cramps, chills was not recovered. The patient was not tested for COVID post vaccination.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood immunoglobulin G, Dizziness, Dysgeusia, Fatigue, Feeling abnormal
Clinical narrative: after getting my first one, I couldn't breathe very well; Everything that I have taken my mouth is feeling terrible; It's hurting my muscle and my arm; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation solution for injection; Batch/Lot Number: EN6207; Expiration Date: 31Jul2021), via an unspecified route of administration, in arm left on 13Mar2021 13:30 PM (at age of 62-year-old) as single dose for Covid-19 immunization. The patient did not take any vaccine four weeks before getting the first shot. The patient's medical history included asthma, ongoing Meniere's disease, and allergic to iodine. The patient's concomitant medications included iodine taken for meniere's disease. On an unspecified date in 2021 (after her first shot), the patient was having a side effect, started feeling symptoms, and could not breathe very well hence they gave her some steroids. She was taking steroids but she had Meniere's disease so she could not have lot of sodium but in that sodium and iodine were there and she was allergic to Iodine. She further added that everything that she had taken in her mouth was feeling terrible, as they gave her steroids after her first one. While asking about the route of administration the patient stated that "It was hurting her muscle and her arm." When probing for mailing address of the facility the patient stated, "No, she have to look it up she have no idea." The patient received treatment with steroids (unspecified vaccine) for the event breathing difficult. The patient underwent laboratory tests and procedures which included blood work showing normal result as her doctor could not find anything but had low sodium and was not gaining so much weight also. The outcome of the events was unknown.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immobile, Meniere's disease
Clinical narrative: after getting my first one, I couldn't breathe very well; Everything that I have taken my mouth is feeling terrible; It's hurting my muscle and my arm; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation solution for injection; Batch/Lot Number: EN6207; Expiration Date: 31Jul2021), via an unspecified route of administration, in arm left on 13Mar2021 13:30 PM (at age of 62-year-old) as single dose for Covid-19 immunization. The patient did not take any vaccine four weeks before getting the first shot. The patient's medical history included asthma, ongoing Meniere's disease, and allergic to iodine. The patient's concomitant medications included iodine taken for meniere's disease. On an unspecified date in 2021 (after her first shot), the patient was having a side effect, started feeling symptoms, and could not breathe very well hence they gave her some steroids. She was taking steroids but she had Meniere's disease so she could not have lot of sodium but in that sodium and iodine were there and she was allergic to Iodine. She further added that everything that she had taken in her mouth was feeling terrible, as they gave her steroids after her first one. While asking about the route of administration the patient stated that "It was hurting her muscle and her arm." When probing for mailing address of the facility the patient stated, "No, she have to look it up she have no idea." The patient received treatment with steroids (unspecified vaccine) for the event breathing difficult. The patient underwent laboratory tests and procedures which included blood work showing normal result as her doctor could not find anything but had low sodium and was not gaining so much weight also. The outcome of the events was unknown.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood sodium, Blood test, Dyspnoea, Taste disorder, Vaccination site pain
Clinical narrative: after getting my first one, I couldn't breathe very well; Everything that I have taken my mouth is feeling terrible; It's hurting my muscle and my arm; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation solution for injection; Batch/Lot Number: EN6207; Expiration Date: 31Jul2021), via an unspecified route of administration, in arm left on 13Mar2021 13:30 PM (at age of 62-year-old) as single dose for Covid-19 immunization. The patient did not take any vaccine four weeks before getting the first shot. The patient's medical history included asthma, ongoing Meniere's disease, and allergic to iodine. The patient's concomitant medications included iodine taken for meniere's disease. On an unspecified date in 2021 (after her first shot), the patient was having a side effect, started feeling symptoms, and could not breathe very well hence they gave her some steroids. She was taking steroids but she had Meniere's disease so she could not have lot of sodium but in that sodium and iodine were there and she was allergic to Iodine. She further added that everything that she had taken in her mouth was feeling terrible, as they gave her steroids after her first one. While asking about the route of administration the patient stated that "It was hurting her muscle and her arm." When probing for mailing address of the facility the patient stated, "No, she have to look it up she have no idea." The patient received treatment with steroids (unspecified vaccine) for the event breathing difficult. The patient underwent laboratory tests and procedures which included blood work showing normal result as her doctor could not find anything but had low sodium and was not gaining so much weight also. The outcome of the events was unknown.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Weight
Clinical narrative: after getting my first one, I couldn't breathe very well; Everything that I have taken my mouth is feeling terrible; It's hurting my muscle and my arm; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation solution for injection; Batch/Lot Number: EN6207; Expiration Date: 31Jul2021), via an unspecified route of administration, in arm left on 13Mar2021 13:30 PM (at age of 62-year-old) as single dose for Covid-19 immunization. The patient did not take any vaccine four weeks before getting the first shot. The patient's medical history included asthma, ongoing Meniere's disease, and allergic to iodine. The patient's concomitant medications included iodine taken for meniere's disease. On an unspecified date in 2021 (after her first shot), the patient was having a side effect, started feeling symptoms, and could not breathe very well hence they gave her some steroids. She was taking steroids but she had Meniere's disease so she could not have lot of sodium but in that sodium and iodine were there and she was allergic to Iodine. She further added that everything that she had taken in her mouth was feeling terrible, as they gave her steroids after her first one. While asking about the route of administration the patient stated that "It was hurting her muscle and her arm." When probing for mailing address of the facility the patient stated, "No, she have to look it up she have no idea." The patient received treatment with steroids (unspecified vaccine) for the event breathing difficult. The patient underwent laboratory tests and procedures which included blood work showing normal result as her doctor could not find anything but had low sodium and was not gaining so much weight also. The outcome of the events was unknown.